← All indications
Hypoxia
Sub-optimal OXYGEN levels in the ambient air of living organisms.
Subtype terms (3)
More specific conditions that are subtypes of Hypoxia in the MeSH hierarchy.
- Fetal Hypoxia
3 drugs approved
- Hypoxia, Brain
15 drugs (14 approved, 1 experimental)
- Platypnea Orthodeoxia Syndrome
Drugs by status
Phase 4 trials (23)
Phase 3 trials (12)
Phase 2 trials (18)
Phase 1 trials (12)
Other trials (25)
- melatonin
- beetroot juice
- carbon dioxide
- cocoa bean
- dark chocolate
- nifedipine
- ethanol
- sevoflurane
- zopiclone
- amoxicillin
- ketone
- red blood cells
- remimazolam
- dipyridamole
- fentanyl
- allogeneic blood cells
- sildenafil
- letrozole
- sodium bicarbonate
- exosomes from mesenchymal stem cells
- hesperidin
- ketone monoester
- nitrate
- fluoromisonidazole
- aspartame
Organizations
Organization Involved with Phase 4 Indications (29)
- Novo Nordisk
- Menarini Group
- United States Army
- University of Manitoba
- Case Western Reserve University
- Chang Gung University
- Indiana University
- Institut National de la Santé Et de la Recherche Médicale, France
- Istituto Auxologico Italiano
- Maria Vittoria Hospital
- Northwestern University
- Negovsky Reanimatology Research Institute
- Sichuan University
- University of Milan
- University of Pavia
- University of Zurich
- University of British Columbia
- University of Copenhagen
- University of Utah
- All India Institute of Medical Sciences
- University of Vienna
- Free University of Amsterdam
- Adolphe Rothschild Ophtalmologic Foundation
- Aristotle University of Thessaloniki
- University of Grenoble
- University of Helsinki
- Government of Kyrgyzstan
- Samaritan Health Services
- Steno Diabetes Center Copenhagen
Organization Involved with Phase 3 Indications (35)
- Hamad Medical Corporation
- Mallinckrodt
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- Aarhus University
- University of Pennsylvania
- American SIDS Institute
- Pakistan Army
- Danish Head and Neck Cancer Group
- Katholieke Universiteit Leuven
- Osaka University
- Stanford University
- Tanta University
- University of Sydney
- Utrecht University
- University of Valencia
- Aalborg University
- Assiut University
- Poznan University
- Scandinavian Critical Care Trials Group
- University of Chicago
- Kafrelsheikh University
- University of Amsterdam
- DAHANCA Danish Head and Neck Group
- University of Porto
- University of Lyon
- University of Ostrava
- University of Paris
- Technical University of Dresden
- +5 more
Organization Involved with Phase 2 Indications (72)
- Celgene
- AesRx
- Schering-Plough
- Genzyme
- Siemens
- Sangart
- National Cancer Institute (NCI)
- Maastricht University
- Ain Shams University
- Augusta University
- Boston University
- Cedars-Sinai Medical Center
- University of London
- Cornell University
- Harvard University
- Duke University
- Georgetown University
- University of Washington
- Johns Hopkins University
- McGuire Research Institute
- Medical University Innsbruck
- New York Medical College
- Radboud University
- Russian Academy of Medical Sciences
- University of East Anglia
- University of Florence
- University of Heidelberg
- University of Iowa
- University of Maryland
- University of Medicine and Dentistry of New Jersey
- +42 more
Organization Involved with Phase 1 Indications (33)
- Actelion
- Roche
- Merck
- GlaxoSmithKline
- Threshold Pharmaceuticals
- Translational Drug Development
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Pittsburgh
- Hebei University
- China Spinal Cord Injury Network
- KK Women's and Children's Hospital
- Loma Linda University
- Nagoya University
- Singapore General Hospital
- University of Malaya
- Chinese University of Hong Kong
- St. Louis University
- University of California, San Diego
- Medical University of South Carolina
- University of Minnesota
- National University of Singapore
- SCRI Development Innovations
- University of Oxford
- University of Texas at Houston
- University of North Carolina at Chapel Hill
- University of Mississippi
- University of Illinois at Chicago
- National Institute for Health Research, United Kingdom
- Thrasher Research Fund
- Government of Singapore
- +3 more
Organization Involved with Other Experimental Indications (51)
- Medical Expeditions Ltd
- ResMed
- HVMN
- United States Navy
- Beijing Anzhen Hospital
- Bangor University
- Cairo University
- Centre Hospitalier Régional d'Orléans
- Centre d’Expertise sur l’Altitude EXALT
- Gachon University
- Gynecologic Oncology Group
- LHL Helse
- Northumbria University
- University of Saskatchewan
- University of Bergen
- Capital Medical University
- Szeged University
- Université catholique de Louvain
- University of Ulm
- AUSL della Romagna-RAVENNA
- International Center for Diarrheal Disease Research
- CHR ORLEANS
- University of Ferrara
- Universita' Cattolica del Sacro Cuore
- British Heart Foundation
- Al Azhar University
- The University of Hong Kong
- Government of China
- Free University of Brussels
- CHU Jean Verdier
- +21 more